about
Open-access clinical trial registries: the Italian scenario.Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.Pharmacological and clinical differences among transmucosal fentanyl formulations for the treatment of breakthrough cancer pain: a review article.Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer.Prevalence of Neuropathic Pain in Cancer Patients: Pooled Estimates From a Systematic Review of Published Literature and Results From a Survey Conducted in 50 Italian Palliative Care Centers.Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study.Assessing the response to opioids in cancer patients: a methodological proposal and the results.Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference.Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids.Learning discloses abnormal structural and functional plasticity at hippocampal synapses in the APP23 mouse model of Alzheimer's disease.Non-clinical factors influencing pain intensity in cancer patients: Socio-cultural-economic status, awareness of disease and the relation with the oncologist.Including cannabinoids in the treatment of painful schwannomatosis.Reply to S. Mercadante et alWorking together to improve the credibility and transparency of clinical research
P50
Q30485749-7BDA7D24-03E8-4865-B7FD-D5FBFA9B5AB0Q36833660-6B7A5DFF-B942-4717-A79A-A12E379BD1E9Q38171975-A34DF2B4-E3FA-4870-A000-A4E2D61F9C85Q38268798-7D6F2AC2-D5FD-474D-BBB4-03ADD3554A3DQ38790355-D92F0AF4-2C8F-4ECA-8DA4-8714FAD835D5Q39179189-FE39ED0A-33B7-4A7F-947D-6A55B7979AD8Q39197627-274E4EB4-EA4F-4F07-8427-50D2DA55DC18Q40586217-B211BB0F-6647-4CDA-AB67-C4AFE3FD98F6Q40873003-F5C5F946-1F82-461D-B726-E28D141432B5Q42470461-D6EDFB1D-40E7-4E19-9E66-C5B09EC692A8Q48056107-76A283CC-3464-4B7B-B6DE-92367AEE7B95Q55662320-E603F7B6-2418-48AB-9738-A611F988708CQ59034332-821BB1C7-ED5D-4951-B162-AE626B71AFDCQ59034424-97545369-2272-43CC-AF31-2FD23E9EC68C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Roberto
@ast
Anna Roberto
@en
Anna Roberto
@es
Anna Roberto
@nl
type
label
Anna Roberto
@ast
Anna Roberto
@en
Anna Roberto
@es
Anna Roberto
@nl
prefLabel
Anna Roberto
@ast
Anna Roberto
@en
Anna Roberto
@es
Anna Roberto
@nl
P1053
K-5040-2016
P106
P21
P31
P3829
P496
0000-0002-6756-1297